How much is Adam Lundin's net worth?
Adaptive Biotechnologies (NASDAQ: ADPT) holds a corporate market capitalization of approximately $3.67 billion USD. As a commercial-stage biotechnology company focused on harnessing the immune system to transform disease diagnostics and therapeutics, its total market valuation fluctuates dynamically during active trading sessions based on clinical trial milestones, diagnostic revenue growth, and broader healthcare market sentiment.
Related FAQs
Investing in mining stocks can be worthwhile for individuals looking to capture the structural megatrends of global electrification, infrastructure development, and resource scarcity. Mining firms supply the essential raw materials required for mo...
Luxshare Precision Industry Co., Ltd. serves as a major contract manufacturer for Apple, assembling millions of iPhones, AirPods, and other consumer electronics devices within its massive advanced manufacturing facilities in China and expanding in...
PSBank offers several savings products, and the specific maintaining balance requirement depends on the type of account opened. For the PSBank Peso Passbook Savings account, the bank requires a minimum maintaining and daily balance of PhP 5,000. I...